(Q35036461)

5 August 2017

title

Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures (English)

1 reference

5 August 2017

1 reference

Michael B Banffy

1

1 reference

5 August 2017

Mark S Vrahas

series ordinal

2

1 reference

5 August 2017

John E Ready

series ordinal

3

1 reference

5 August 2017

John A Abraham

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

25 February 2011

1 reference

Clinical Orthopaedics and Related Research

5 August 2017

published in

1 reference

5 August 2017

volume

469

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

2028-2034

1 reference

https://scigraph.springernature.com/pub.10.1007/s11999-011-1828-8

5 August 2017

exact match

0 references

cites work

Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

When is a fracture healed? Radiographic and clinical criteria revisited

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Case reports: two femoral insufficiency fractures after long-term alendronate therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Low-energy femoral shaft fractures associated with alendronate use.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Severely suppressed bone turnover: a potential complication of alendronate therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Evolving data about subtrochanteric fractures and bisphosphonates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Fragility fractures of the hip and femur: incidence and patient characteristics

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111775

Stress fractures of the femoral neck

25 October 2018

1 reference

12 December 2020

Fracture and dislocation compendium. Orthopaedic Trauma Association Committee for Coding and Classification

1 reference

12 December 2020

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

1 reference

12 December 2020

Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk

1 reference

12 December 2020

10.1007/S11999-011-1828-8

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference